Robert Ticktin
Direttore operativo presso PMV PHARMACEUTICALS, INC.
Posizioni attive di Robert Ticktin
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PMV PHARMACEUTICALS, INC. | Direttore operativo | - | - |
| Consigliere Generale | - | - |
Storia della carriera di Robert Ticktin
Precedenti posizioni note di Robert Ticktin
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TESARO INC | Corporate Officer/Principal | - | - |
EPIRUS Biopharmaceuticals, Inc. /Old/
 EPIRUS Biopharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology EPIRUS Biopharmaceuticals, Inc. develops monoclonal antibodies. It offers pharmaceutical products. The company is headquartered in Boston, MA. | Consigliere Generale | 01/04/2014 | - |
| EPIRUS BIOPHARMACEUTICALS, INC. | Consigliere Generale | - | - |
| Segretario Aziendale | - | - | |
Zalicus, Inc.
 Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA. | Consigliere Generale | - | - |
Formazione di Robert Ticktin
| The Ohio State University | Undergraduate Degree |
| Fordham University School of Law | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
Posizioni
| General Counsel | 4 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| EPIRUS BIOPHARMACEUTICALS, INC. | Health Technology |
| PMV PHARMACEUTICALS, INC. | Commercial Services |
| Aziende private | 3 |
|---|---|
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA. | Health Technology |
EPIRUS Biopharmaceuticals, Inc. /Old/
EPIRUS Biopharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology EPIRUS Biopharmaceuticals, Inc. develops monoclonal antibodies. It offers pharmaceutical products. The company is headquartered in Boston, MA. | Health Technology |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Robert Ticktin
- Esperienza
